Browsing: Merck
Lynparza (olaparib), a product of Fortune 500 pharmaceutical firm Merck and Fortune 500 Europe company AstraZeneca, showed meaningful improvements in…
Stocks of major drug makers and biotech companies tumbled in trading late this week after President-elect Donald Trump announced that…
Respiratory virus season has arrived, and hopefully you’re up to date on vaccinations that can help prevent infectious diseases including…
InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here. Across the United States,…
InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here. Around 25 million Americans…
InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here. The American Society of…
Tableau unveiled new data tools for the rest of us in San Diego yesterday, mostly powered by AI. Hyped-up product…
British patients are trying a first-of-its-kind customized vaccine for skin cancer as part of a international trial. The shots —…
The Food and Drug Administration approved Winrevair last week. The drug is indicated for a rare and deadly cardiovascular disorder…
Amid a frenzy for AI-related stocks, shares of a little-known biotech company in South Korea got an Nvidia-esque boost. Alteogen,…